Skip to content
sellWeak cluster of 210b5-1 plan

Conrad Wai sold $693k of CLOV

CEO, Counterpart Health at CLOVER HEALTH INVESTMENTS, CORP. /DE. 209,797 shares at an average of $3.30, traded Jul 22, 2025, filed Jul 24, 2025.

Warning score
39
Value
$693k
209,797 shares
Holdings after
1,403,701
-13% from before
From 52-week low
+26%
low $2.56, close $3.22
From 52-week high
-33%
high $4.82, as of Jul 22, 2025

Score components

  • Role
    CEO
    +25
  • Trade size
    $693k at market
    +21
  • Share of holdings sold
    Sold 13% of holdings
    +5
  • Cluster
    2 insiders selling within 14 days
    +8
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -11.2%, 3m +4.1%, 6m -12.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CLOVOct 12, 2026 · close 4.78
Since filing Jul 24, 2025: +55.4%SPY +24.3% · excess +31.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001801170-25-000176, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jul 22, 2025SOpen-market sale
Class A Common Stockindirect: By Trust.10b5-1
-118,600$3.29$390k1,494,898Jul 24, 2025
Jul 23, 2025SOpen-market sale
Class A Common Stockindirect: By Trust.10b5-1
-91,197$3.32$303k1,403,701Jul 24, 2025

Related signals

Other insiders at CLOVER HEALTH INVESTMENTS, CORP. /DE and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
Pro nowfree Oct 14, 2026
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$9,288
2,006 shares
-0%
19Weak
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$39k
8,750 shares
-0%
38Weak
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Andrew Toy
Chief Executive Officer
$1.3M
318,806 shares
-3%
20Weak
CLOVsell 510b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$8,760
1,921 shares
-0%
10Weak
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Joseph Frank Oldakowski
VP OF FINANCE AND CONTROLLER
$15k
3,170 shares
-1%
50Moderate
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Conrad Wai
CEO, Counterpart Health
$1.4M
300,000 shares
-20%
26Weak
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$44k
9,273 shares
-0%
16Weak
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Karen Soares
Chief Legal Officer
$33k
6,846 shares
-0%
40Moderate
CLOVsell 4
CLOVER HEALTH INVESTMENTS, CORP. /DE
Joseph Frank Oldakowski
VP OF FINANCE AND CONTROLLER
$103k
20,000 shares
-7%
19Weak
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Joseph Clay Thornton
Interim CFO
$78k
17,775 shares
-1%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Conrad Wai sold $693k of CLOV | InsiderTell